Hot Features
プレミアム
ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product candidates address therapeutic areas with a high unmet medical need and strive to provide improved patient be... Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product candidates address therapeutic areas with a high unmet medical need and strive to provide improved patient benefit by delivering targeted, long-lasting activity with fewer side effects. Its lead product candidate, EP-104IAR, is in development for the treatment of pain due to osteoarthritis of the knee. In addition, it is developing a pipeline of earlier-stage long-acting formulations. 詳細を表示
Eupraxia's DiffuSphere™ Technology Demonstrates Targeted Drug Release while Minimizing Systemic Exposure for a Period of More Than Six Months PR Newswire VICTORIA, BC, Nov. 20, 2024...
Eupraxia Pharmaceuticals to Present at American College of Rheumatology Convergence 2024 Annual Meeting PR Newswire VICTORIA, BC, Nov. 14, 2024 VICTORIA, BC, Nov. 14, 2024 /PRNewswire/ - Eupraxia...
Eupraxia Pharmaceuticals' CEO Dr. James Helliwell to Participate in Webinar Event, "Eosinophilic Esophagitis: The Emerging Digestive Disorder Frequently Misdiagnosed", on November...
Eupraxia Pharmaceuticals Announces Positive Data from Fifth Cohort of RESOLVE Phase 1b/2a Trial of EP-104GI for Treatment of Eosinophilic Esophagitis PR Newswire VICTORIA, BC, Nov. 12, 2024 One...
Eupraxia Pharmaceuticals Reports Third Quarter 2024 Financial Results PR Newswire VICTORIA, BC, Nov. 7, 2024 VICTORIA, BC, Nov. 7, 2024 /PRNewswire/ - Eupraxia Pharmaceuticals Inc...
| 期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.1543 | -5.05901639344 | 3.05 | 3.2 | 2.85 | 3388 | 2.97908341 | CS |
| 4 | -0.2043 | -6.59032258065 | 3.1 | 3.24 | 2.84 | 5185 | 3.0657795 | CS |
| 12 | -0.2743 | -8.65299684543 | 3.17 | 4.08 | 2.75 | 13662 | 3.33749789 | CS |
| 26 | 0.1457 | 5.29818181818 | 2.75 | 4.08 | 2.2 | 11334 | 3.09105216 | CS |
| 52 | -0.6543 | -18.4309859155 | 3.55 | 4.08 | 2.2 | 15181 | 2.94987922 | CS |
| 156 | -0.6543 | -18.4309859155 | 3.55 | 4.08 | 2.2 | 15181 | 2.94987922 | CS |
| 260 | -0.6543 | -18.4309859155 | 3.55 | 4.08 | 2.2 | 15181 | 2.94987922 | CS |
| 銘柄コード | 株価 | 出来高 |
|---|---|---|
| TCTMTCTM Kids IT Education Inc | US$ 0.764 (321.87%) | 729.71M |
| NVDANVIDIA Corporation | US$ 120.07 (-3.67%) | 388.53M |
| RIMEAlgorhythm Holdings Inc | US$ 0.02565 (5.12%) | 338.7M |
| BHATBlue Hat Interactive Entertainment Technology | US$ 0.0355 (-11.25%) | 236.05M |
| CLEUChina Liberal Education Holdings Ltd | US$ 0.1938 (30.77%) | 234.74M |
trunkmonk
5分前
janice shell
5分前
boston745
6分前
shurtha2000
6分前
dragoon76
7分前
KevGee59
7分前
ddls
8分前
BDEZ
8分前
KevGee59
8分前
Researchfyi
9分前
BDEZ
10分前
Guzzi62
10分前
newmedman
11分前
stervc
11分前
BDEZ
13分前
georgejjl
14分前
BDEZ
14分前
janice shell
16分前
Horseb4CarT
17分前
ddls
18分前
newmedman
20分前
hssbwwmp
21分前
quicksniff
21分前
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
